Patent details

Basic Information

Publication number:

LUC00374

Type:

SPC

SPC Type:

Medical

Basic Patent Number:

EP168323467

Legal Status:

Pending & Published

Application number:

LUC00374

First applicant's nationality:

Procedural language:

English

Marketing Authorization

Marketing Authorization Number:

EU/1/24/1833

Marketing Authorization Type:

Marketing Authorization Date:

25/07/2024

Marketing Authorization Status:

Accepted

Marketing Authorization Country:

Luxembourg (LU)

Dates

Filing date:

19/12/2024

First Marketing Authorization date:

25/07/2024

Grant date:

Activation date:

Publication date:

20/12/2024

Lapsed date:

Expiration date:

Renunciation date:

Revocation date:

Annulment date:

Basic SPC Expiration:

25/07/2039

SPC Extension Expiration:

25/07/2039

Rejection date:

Withdrawal date:

Owner

From:

19/12/2024

 

 

Name:

WuXi Biologics (Shanghai) Co., Ltd.

Address:

288 Fute Zhong Road Waigaoqiao Free Trade Zone, Shanghai 200131, China (CN)

Name:

WuXi Biologics Ireland Limited

Address:

Mullagharlin, Dundalk, Co Louth A91 X56F, Ireland (IE)

Agent

Name:

Dennemeyer & Associates S.A.

From:

19/12/2024

Address:

55, rue des Bruyères, L-1274, HOWALD, Luxembourg (LU)

To:

Publication

Bulletin

Bulletin Heading:

SPC1

Bulletin edition number:

2025/01

Publication date:

06/01/2025

Description:

Section C : Published requests for Supplementary Protection Certificates – I1 publication

Annual Fees

Annual Fee Due Date:

01/09/2036

Annual Fee Number:

21

Annual Fee Amount:

410 Euro

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages
19/12/2024	Application Form	6
19/12/2024	Summary of the product caracteristics	37
19/12/2024	General Document	4
19/12/2024	Marketing authorization	3
19/12/2024	MA publication	12
20/12/2024	Outgoing Correspondence	1
20/12/2024	Publication	1